Crystal modification of phenytoin using different solvents and crystallization conditions

Alderborn, 1996, Particle dimensions, 245

Alderborn, 1982, Studies on direct compression of tablets. Part 4. Effect of particle size on the mechanical strength of tablets, Acta. Pharm. Suec., 19, 381

Alderborn, 1982, Studies on direct compression of tablets. Part 3. Effect on tablet strength of changes in particle shape and texture obtained by milling, Acta Pharm. Suec., 19, 147

Berkovitch-Yellin, 1985, Toward an ab initio derivation of crystal morphology, J. Am. Chem. Soc., 107, 8239, 10.1021/ja00312a070

Bolourtchian, N., 2001. The use of recrystallization in modification of physicomechanical properties of phenytoin and carbamazepin. PhD Thesis, Tehram Medical Sciences University.

Burt, 1980, Effect of habit modification on dissolution rate, Int. J. Pharm., 5, 239, 10.1016/0378-5173(80)90131-3

Chow, 1991, Modification of phenytoin crystals: Influence of 3-acetoxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties, Int. J. Pharm., 75, 219, 10.1016/0378-5173(91)90196-U

Chow, 1985, Modification of acetaminophen crystals: influence of growth in aqueous solutions containing p-acetoxyacetanilide on crystal properties, Int. J. Pharm., 24, 239, 10.1016/0378-5173(85)90024-9

Chow, 1995, Modification of phenytoin crystals: III: Influence of 3-butanoyloxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties, Int. J. Pharm., 126, 11, 10.1016/0378-5173(95)04059-5

Di Martino, 2000, Improved compression properties of propyphenazone spherical crystals, Int. J. Pharm., 197, 95, 10.1016/S0378-5173(99)00455-X

Femi-Oyewo, 1994, Studies on paracetamol crystals produced by growth in aqueous solutions, Int. J. Pharm., 112, 17, 10.1016/0378-5173(94)90257-7

Franco, 2001, Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and polyvinylpyrollidone K-30 solid dispersions, Int. J. Pharm., 225, 63, 10.1016/S0378-5173(01)00751-7

Garekani, 1999, Formation and compression characteristics of prismatic polyhedral crystal and thin plate like crystals of paracetamol, Int. J. Pharm., 187, 77, 10.1016/S0378-5173(99)00157-X

Garekani, 2000, Highly compressible paracetamol: crystallization and characterization, Int. J. Pharm., 208, 87, 10.1016/S0378-5173(00)00550-0

Garekani, 2000, Highly compressible paracetamol: compression properties, Int. J. Pharm., 208, 101, 10.1016/S0378-5173(00)00551-2

Gordon, 1992, Modification of phenytoin crystals: influence of 3-propanoyloxymethyl-5, 5-diphenylhydantoin on solution-phase crystallization and related crystal properties, Int. J. Pharm., 79, 171, 10.1016/0378-5173(92)90108-E

Kachrimanis, 1998, Crystallization conditions and physicomechanical properties, of ibuprofen-Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique, Int. J. Pharm., 173, 61, 10.1016/S0378-5173(98)00191-4

Kaul, 1992, Crystal habit modifications and altered tableting characteristics, Int. J. Pharm., 88, 345, 10.1016/0378-5173(92)90333-W

Khamskii, 1976, Some problems of crystal habit modification, 203

Lahva, 2001, The effect of solvent on crystal growth and morphology, Chem. Eng. Sci., 56, 2245, 10.1016/S0009-2509(00)00459-0

Marshall, 1989, Crystallization solvent induced solid-state and particulate modifications of nitrofurantoin, Int. J. Pharm., 55, 257, 10.1016/0378-5173(89)90049-5

Mullin, 1993, 1

Parfitt, 1999, 342

Watanabe, 1982, Crystal habits and dissolution behavior of aspirin, Chem. Pharm. Bull., 30, 2958, 10.1248/cpb.30.2958

Wong, 1990, Effect of particle shape on the mechanical properties of powders, Int. J. Pharm., 59, 145, 10.1016/0378-5173(90)90089-M